| Line Item | 2026-01-01 | Y/Y |
|---|---|---|
| Revenue | $243.2M | +1.0% |
| Cost of Revenue | $13.0M | -5.1% |
| R&D Expense | $3.1M | -6.1% |
| SG&A Expense | $46.1M | -9.1% |
| Operating Income | -$13.9M | +28.7% |
| Interest Expense | $600K | -64.7% |
| Pre-tax Income | -$10.6M | +52.0% |
| Income Tax | $0 | -100.0% |
| Net Income | -$10.6M |
| Line Item | 2026-01-01 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.6M | -53.9% |
| Accounts Receivable | $96.5M | +13.1% |
| Current Assets | $138.1M | -22.4% |
| Total Assets | $490.6M | -13.7% |
| Current Liabilities | $62.1M | -15.5% |
| Long-term Debt | $12.0M | +20.0% |
| Total Liabilities | $115.2M | -26.8% |
| Line Item | 2026-01-01 | Y/Y |
|---|---|---|
| Operating Cash Flow | $8.4M | -86.1% |
| Capital Expenditures | $5.6M | -3.4% |
| Investing Cash Flow | -$15.4M | -170.2% |
| Financing Cash Flow | -$33.5M | -137.6% |
| Free Cash Flow | $2.8M | -94.9% |
| +52.5% |
| EPS (Basic) | -$0.11 | +52.2% |
| EPS (Diluted) | -$0.11 | +52.2% |
| Stockholders' Equity |
| $375.4M |
| -8.7% |